Eli Lilly Total Non-Operating Income/Expense 2010-2024 | LLY

Eli Lilly total non-operating income/expense for the twelve months ending September 30, 2024 was $-0.274B, a 90.01% decline year-over-year.

  • Eli Lilly annual total non-operating income/expense for 2023 was $0.097B, a 130.13% decline from 2022.
  • Eli Lilly annual total non-operating income/expense for 2022 was $-0.321B, a 59.18% increase from 2021.
  • Eli Lilly annual total non-operating income/expense for 2021 was $-0.202B, a 117.2% decline from 2020.

Eli Lilly Total Non-Operating Income/Expense 2010-2024 | LLY

  • Eli Lilly annual total non-operating income/expense for 2023 was $0.097B, a 130.13% decline from 2022.
  • Eli Lilly annual total non-operating income/expense for 2022 was $-0.321B, a 59.18% increase from 2021.
  • Eli Lilly annual total non-operating income/expense for 2021 was $-0.202B, a 117.2% decline from 2020.